Universal Health Services First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Advertisement

Universal Health Services (NYSE:UHS) First Quarter 2025 Results

Key Financial Results

  • Revenue: US$4.10b (up 6.7% from 1Q 2024).
  • Net income: US$316.7m (up 21% from 1Q 2024).
  • Profit margin: 7.7% (up from 6.8% in 1Q 2024). The increase in margin was driven by higher revenue.
  • EPS: US$4.87 (up from US$3.90 in 1Q 2024).
We've discovered 1 warning sign about Universal Health Services. View them for free.
earnings-and-revenue-growth
NYSE:UHS Earnings and Revenue Growth April 30th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Universal Health Services EPS Beats Expectations, Revenues Fall Short

Revenue missed analyst estimates by 1.3%. Earnings per share (EPS) exceeded analyst estimates by 9.7%.

Looking ahead, revenue is forecast to grow 5.2% p.a. on average during the next 3 years, compared to a 7.0% growth forecast for the Healthcare industry in the US.

Performance of the American Healthcare industry.

The company's shares are up 6.6% from a week ago.

Risk Analysis

What about risks? Every company has them, and we've spotted 1 warning sign for Universal Health Services you should know about.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NYSE:UHS

Universal Health Services

Through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities in the United States.

Very undervalued with outstanding track record.

Advertisement

Weekly Picks

LO
Lou_Basenese
GANX logo
Lou_Basenese on Gain Therapeutics ·

The Market Is Sleeping on This Parkinson's Biotech - And I Think That's a Mistake

Fair Value:US$7.671.8% undervalued
18 users have followed this narrative
0 users have commented on this narrative
16 users have liked this narrative
KI
NVDA logo
Kingman1152 on NVIDIA ·

NVIDIA will see a profit margin surge of 55% in the next 5 years

Fair Value:US$305.234.8% undervalued
50 users have followed this narrative
1 users have commented on this narrative
17 users have liked this narrative
TE
BUSER logo
TechMegaTrends on Bambuser ·

Bambuser is today the only listed company in Europe that simultaneously possesses an 85% gross margin, proprietary AI infrastructure for the

Fair Value:SEK 238.2685.8% undervalued
33 users have followed this narrative
0 users have commented on this narrative
13 users have liked this narrative
HE
HedgeY
CSTM logo
HedgeY on Constellium ·

Constellium jet another cyclical aluminum processor, or a mispriced aluminum platform?

Fair Value:US$3412.8% undervalued
5 users have followed this narrative
0 users have commented on this narrative
4 users have liked this narrative

Updated Narratives

FA
ORGABIO logo
FA_Trader on Orgabio Holdings Berhad ·

Orgabio: A niche beverage manufacturer that is starting to show stronger scale, improving margins, and clearer earnings traction

Fair Value:RM 0.4839.6% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
TH
LMT logo
TheBestInvestor on Lockheed Martin ·

Orbit + Aero + Defense

Fair Value:US$673.889.3% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
JI
BFBIO logo
jibran5237 on BF Biosciences ·

BFBIO is a long-duration growth platform

Fair Value:PK₨554.0472.2% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

TR
tripledub
MSFT logo
tripledub on Microsoft ·

Everyone's Terrified Microsoft Will Keep Spending. I'm Terrified They'll Stop.

Fair Value:US$3954.1% overvalued
49 users have followed this narrative
3 users have commented on this narrative
42 users have liked this narrative
AN
AnalystConsensusTarget
MSFT logo
AnalystConsensusTarget on Microsoft ·

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks

Fair Value:US$587.3130.0% undervalued
1363 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative
RO
Robbo
TSLA logo
Robbo on Tesla ·

The academically fascinating Tesla

Fair Value:US$301.2k% overvalued
38 users have followed this narrative
11 users have commented on this narrative
32 users have liked this narrative